In this webinar, you’ll learn:

Select an AI tool that performs reliably across all imaging types and extracts key findings automatically

Find a navigator to guide every identified patient through scheduling and next steps

Standardize on one evidence-based guideline with clearly defined patient pathways

Choose a centralized or decentralized model that fits your resources and geography

Drive long-term adherence with integrated communication and no-show outreach

Sustain awareness by educating referring physicians and sharing results with leadership

Meet the speakers

Dr. Russell Langan, MD, FACS, FSSO

Associate Chief Surgical Officer, RWJBarnabas Health, RCINJ; Director of Surgical Oncology, RWJBarnabas Health Northern Region; Associate Professor of Surgery, Rutgers Cancer Institute

Dr. Russell Langan is a surgical oncologist specializing in tumors of the pancreas, liver, bile ducts, gallbladder, and intestinal tract, and Chief of Surgical Oncology & Hepatopancreatobiliary Surgery at Cooperman Barnabas Medical Center. He leads the highest-volume pancreatic surgery program in New Jersey and pioneered the use of AI to identify and survey pancreatic cysts so cancers can be treated sooner. He trained at Georgetown University Hospital, the National Cancer Institute, and Memorial Sloan Kettering Cancer Center, and is an Associate Professor of Surgery at Rutgers Robert Wood Johnson Medical School.

Ready to get started?

Bring this level of early detection to your
health system

SMH grew incidental lung findings routed to its nodule clinic 100x and now detects
lung cancer at more than twice the national early-stage rate. Talk to our team about
building the same kind of program.

Contact Us